{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:01:51Z","timestamp":1772888511755,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Yinchuan Science and Technology Tackling Project","award":["2023SFZD02"],"award-info":[{"award-number":["2023SFZD02"]}]},{"name":"the Yinchuan Science and Technology Tackling Project","award":["2023SFZD02"],"award-info":[{"award-number":["2023SFZD02"]}]},{"name":"Special Funds for the Central Government to Guide Local Scientific and Technological Development","award":["2024FRD05067"],"award-info":[{"award-number":["2024FRD05067"]}]},{"name":"Special Funds for the Central Government to Guide Local Scientific and Technological Development","award":["2024FRD05067"],"award-info":[{"award-number":["2024FRD05067"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-04470-x","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:23:30Z","timestamp":1751387010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploration of shared pathogenic factors and causative genes in early-stage endometrial cancer and osteoarthritis"],"prefix":"10.1038","volume":"15","author":[{"given":"Yiyun","family":"Bai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruzhen","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"4470_CR1","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","volume":"399","author":"EJ Crosbie","year":"2022","unstructured":"Crosbie, E. J. et al. Endometrial cancer. Lancet 399, 1412\u20131428 (2022).","journal-title":"Lancet"},{"key":"4470_CR2","first-page":"258","volume":"69","author":"RA Brooks","year":"2019","unstructured":"Brooks, R. A. et al. Current recommendations and recent progress in endometrial cancer. CA Cancer J. Clin. 69, 258\u2013279 (2019).","journal-title":"CA Cancer J. Clin."},{"key":"4470_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12943-023-01757-3","volume":"22","author":"Y Shen","year":"2023","unstructured":"Shen, Y., Yang, W., Liu, J. & Zhang, Y. Minimally invasive approaches for the early detection of endometrial cancer. Mol. Cancer 22, 53 (2023).","journal-title":"Mol. Cancer"},{"key":"4470_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/path.5608","volume":"253","author":"J Huvila","year":"2021","unstructured":"Huvila, J., Pors, J., Thompson, E. F. & Gilks, C. B. Endometrial carcinoma: Molecular subtypes, precursors and the role of pathology in early diagnosis. J. Pathol. 253, 355\u2013365 (2021).","journal-title":"J. Pathol."},{"key":"4470_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/bjc.1988.44","volume":"57","author":"TJ Key","year":"1988","unstructured":"Key, T. J. & Pike, M. C. The dose-effect relationship between \u2018unopposed\u2019 oestrogens and endometrial mitotic rate: Its central role in explaining and predicting endometrial cancer risk. Br. J. Cancer 57, 205\u2013212 (1988).","journal-title":"Br. J. Cancer"},{"key":"4470_CR6","doi-asserted-by":"publisher","first-page":"907750","DOI":"10.3389\/fimmu.2022.907750","volume":"13","author":"U Nedunchezhiyan","year":"2022","unstructured":"Nedunchezhiyan, U. et al. Obesity, inflammation, and immune system in osteoarthritis. Front. Immunol. 13, 907750 (2022).","journal-title":"Front. Immunol."},{"key":"4470_CR7","first-page":"12076","volume":"2","author":"J Martel-Pelletier","year":"2016","unstructured":"Martel-Pelletier, J. et al. Osteoarthritis. Nat. Rev. Dis. Prim. 2, 12076 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"4470_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-021-02193-0","volume":"20","author":"E Bouras","year":"2022","unstructured":"Bouras, E. et al. Circulating inflammatory cytokines and risk of five cancers: A Mendelian randomization analysis. BMC Med. 20, 1\u201315 (2022).","journal-title":"BMC Med."},{"key":"4470_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41413-023-00280-x","volume":"11","author":"H Pang","year":"2023","unstructured":"Pang, H. et al. Low back pain and osteoarthritis pain: A perspective of estrogen. Bone Res. 11, 42 (2023).","journal-title":"Bone Res."},{"key":"4470_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12916-022-02322-3","volume":"20","author":"E Hazelwood","year":"2022","unstructured":"Hazelwood, E. et al. Identifying molecular mediators of the relationship between body mass index and endometrial cancer risk: A Mendelian randomization analysis. BMC Med. 20, 125 (2022).","journal-title":"BMC Med."},{"key":"4470_CR11","doi-asserted-by":"publisher","first-page":"9208","DOI":"10.3390\/ijms22179208","volume":"22","author":"V Molnar","year":"2021","unstructured":"Molnar, V. et al. Cytokines and chemokines involved in osteoarthritis pathogenesis. Int. J. Mol. Sci. 22, 9208 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"4470_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/AOG.0b013e31820205b3","volume":"117","author":"VE von Gruenigen","year":"2011","unstructured":"von Gruenigen, V. E. et al. Lifestyle challenges in endometrial cancer survivorship. Obstet. Gynecol. 117, 93\u2013100 (2011).","journal-title":"Obstet. Gynecol."},{"key":"4470_CR13","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/jbmr\/zjae136","volume":"39","author":"CE Lovegrove","year":"2024","unstructured":"Lovegrove, C. E., Howles, S. A., Furniss, D. & Holmes, M. V. Causal inference in health and disease: A review of the principles and applications of Mendelian randomization. J. Bone Miner. Res. 39, 1539\u20131552 (2024).","journal-title":"J. Bone Miner. Res."},{"key":"4470_CR14","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jacc.2022.06.007","volume":"80","author":"BA Ference","year":"2022","unstructured":"Ference, B. A. Interpreting the clinical implications of drug-target Mendelian randomization studies. J. Am. Coll. Cardiol. 80, 663\u2013665 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"4470_CR15","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1093\/brain\/awad070","volume":"146","author":"J Lin","year":"2023","unstructured":"Lin, J., Zhou, J. & Xu, Y. Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis. Brain 146, 3364\u20133372 (2023).","journal-title":"Brain"},{"key":"4470_CR16","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1186\/s12967-023-04474-z","volume":"21","author":"Y Cao","year":"2023","unstructured":"Cao, Y., Yang, Y., Hu, Q. & Wei, G. Identification of potential drug targets for rheumatoid arthritis from genetic insights: A Mendelian randomization study. J. Transl. Med. 21, 616 (2023).","journal-title":"J. Transl. Med."},{"key":"4470_CR17","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.jacc.2015.02.020","volume":"65","author":"BA Ference","year":"2015","unstructured":"Ference, B. A., Majeed, F., Penumetcha, R., Flack, J. M. & Brook, R. D. Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both. J. Am. Coll. Cardiol. 65, 1552\u20131561 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"4470_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","volume":"385","author":"DI Swerdlow","year":"2015","unstructured":"Swerdlow, D. I. et al. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: Evidence from genetic analysis and randomised trials. Lancet 385, 351\u2013361 (2015).","journal-title":"Lancet"},{"key":"4470_CR19","doi-asserted-by":"publisher","first-page":"e1009238","DOI":"10.1371\/journal.pcbi.1009238","volume":"17","author":"R Schwartz","year":"2021","unstructured":"Schwartz, R., Gagliano Taliun, S. A. & Evans, D. M. Ten simple rules for conducting a Mendelian randomization study. PLOS Comput. Biol. 17, e1009238 (2021).","journal-title":"PLOS Comput. Biol."},{"key":"4470_CR20","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova, V. W. et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization. JAMA 326, 1614\u20131621 (2021).","journal-title":"JAMA"},{"key":"4470_CR21","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47\u2013e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"4470_CR22","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"4470_CR23","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"28","key":"4470_CR24","first-page":"27","volume":"1","author":"MKS Goto","year":"2000","unstructured":"Goto, M. K. S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1(28), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"4470_CR25","doi-asserted-by":"publisher","first-page":"e6829","DOI":"10.1002\/cam4.6829","volume":"13","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. The causal relationship between osteoarthritis and bladder cancer: A Mendelian randomization study. Cancer Med. 13, e6829 (2023).","journal-title":"Cancer Med."},{"key":"4470_CR26","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.18632\/aging.205945","volume":"16","author":"X Cheng","year":"2024","unstructured":"Cheng, X. et al. The crosstalk role of CDKN2A between tumor progression and cuproptosis resistance in colorectal cancer. Aging 16, 10512\u201310538 (2024).","journal-title":"Aging"},{"key":"4470_CR27","doi-asserted-by":"publisher","first-page":"1090596","DOI":"10.3389\/fimmu.2023.1090596","volume":"14","author":"B Chang","year":"2023","unstructured":"Chang, B., Hu, Z., Chen, L., Jin, Z. & Yang, Y. Development and validation of cuproptosis-related genes in synovitis during osteoarthritis progress. Front. Immunol. 14, 1090596 (2023).","journal-title":"Front. Immunol."},{"key":"4470_CR28","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.joca.2021.02.564","volume":"29","author":"J Zhou","year":"2021","unstructured":"Zhou, J. et al. Genetically predicted circulating levels of copper and zinc are associated with osteoarthritis but not with rheumatoid arthritis. Osteoarthr. Cartil. 29, 1029\u20131035 (2021).","journal-title":"Osteoarthr. Cartil."},{"key":"4470_CR29","doi-asserted-by":"publisher","first-page":"17578","DOI":"10.3390\/ijms242417578","volume":"24","author":"RA Conforti","year":"2023","unstructured":"Conforti, R. A., Delsouc, M. B., Zorychta, E., Telleria, C. M. & Casais, M. Copper in gynecological diseases. Int. J. Mol. Sci. 24, 17578 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"4470_CR30","doi-asserted-by":"publisher","first-page":"1459183","DOI":"10.3389\/fcell.2024.1459183","volume":"12","author":"X Huang","year":"2024","unstructured":"Huang, X., Lian, M. & Li, C. Copper homeostasis and cuproptosis in gynecological cancers. Front. Cell Dev. Biol. 12, 1459183 (2024).","journal-title":"Front. Cell Dev. Biol."},{"key":"4470_CR31","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nm.4324","volume":"23","author":"OH Jeon","year":"2017","unstructured":"Jeon, O. H. et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat. Med. 23, 775\u2013781 (2017).","journal-title":"Nat. Med."},{"key":"4470_CR32","doi-asserted-by":"publisher","first-page":"13238","DOI":"10.1038\/srep13238","volume":"5","author":"L Su","year":"2015","unstructured":"Su, L., Wang, H., Miao, J. & Liang, Y. Clinicopathological significance and potential drug target of CDKN2A\/p16 in endometrial carcinoma. Sci. Rep. 5, 13238 (2015).","journal-title":"Sci. Rep."},{"key":"4470_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00401-023-02571-3","volume":"146","author":"JZ Wang","year":"2023","unstructured":"Wang, J. Z. et al. Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas. Acta Neuropathol. 146, 145\u2013162 (2023).","journal-title":"Acta Neuropathol."},{"key":"4470_CR34","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1111\/jcmm.13084","volume":"21","author":"L Cheng","year":"2017","unstructured":"Cheng, L. et al. DDA1, a novel oncogene, promotes lung cancer progression through regulation of cell cycle. J. Cell Mol. Med. 21, 1532\u20131544 (2017).","journal-title":"J. Cell Mol. Med."},{"key":"4470_CR35","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.1038\/s41467-024-50584-7","volume":"15","author":"DA Llerena","year":"2024","unstructured":"Llerena, D. A. et al. The small CRL4CSA ubiquitin ligase component DDA1 regulates transcription-coupled repair dynamics. Nat. Commun. 15, 6374 (2024).","journal-title":"Nat. Commun."},{"key":"4470_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11926-021-01022-w","volume":"23","author":"Y Liu","year":"2021","unstructured":"Liu, Y., Molchanov, V. & Yang, T. Enzymatic machinery of ubiquitin and ubiquitin-like modification systems in chondrocyte homeostasis and osteoarthritis. Curr. Rheumatol. Rep. 23, 62 (2021).","journal-title":"Curr. Rheumatol. Rep."},{"key":"4470_CR37","doi-asserted-by":"publisher","first-page":"112026","DOI":"10.1016\/j.intimp.2024.112026","volume":"132","author":"Y Lin","year":"2024","unstructured":"Lin, Y. et al. Novel insights into the role of ubiquitination in osteoarthritis. Int. Immunopharmacol. 132, 112026 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"4470_CR38","doi-asserted-by":"publisher","first-page":"177237","DOI":"10.1016\/j.ejphar.2024.177237","volume":"989","author":"PF Wong","year":"2025","unstructured":"Wong, P. F. & Kamarul, T. Targeting Ubiquitin-Proteasome system (UPS) in treating osteoarthritis. Eur. J. Pharmacol. 989, 177237 (2025).","journal-title":"Eur. J. Pharmacol."},{"key":"4470_CR39","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1142\/S0192415X23500234","volume":"51","author":"J Zhang","year":"2023","unstructured":"Zhang, J. et al. Dihydroartemisinin affects STAT3\/DDA1 signaling pathway and reverses breast cancer resistance to cisplatin. Am. J. Chin. Med. 51, 445\u2013459 (2023).","journal-title":"Am. J. Chin. Med."},{"key":"4470_CR40","doi-asserted-by":"publisher","first-page":"19794","DOI":"10.18632\/oncotarget.7847","volume":"7","author":"S Zhao","year":"2016","unstructured":"Zhao, S. et al. DDA1 promotes stage IIB\u2013IIC colon cancer progression by activating NF\u03baB\/CSN2\/GSK-3\u03b2 signaling. Oncotarget 7, 19794\u201319812 (2016).","journal-title":"Oncotarget"},{"key":"4470_CR41","doi-asserted-by":"publisher","first-page":"16899","DOI":"10.1038\/s41598-023-44189-1","volume":"13","author":"S Ma","year":"2023","unstructured":"Ma, S., Chen, Q., Li, X., Fu, J. & Zhao, L. UBE2C serves as a prognosis biomarker of uterine corpus endometrial carcinoma via promoting tumor migration and invasion. Sci. Rep. 13, 16899 (2023).","journal-title":"Sci. Rep."},{"key":"4470_CR42","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.1038\/s41598-025-88467-6","volume":"15","author":"R Huang","year":"2025","unstructured":"Huang, R., Yao, J., Liu, L., Li, H. & Huang, B. Comprehensive analysis of LRRC42 as a potential biomarker and key cellular processes in cancer development. Sci. Rep. 15, 5169 (2025).","journal-title":"Sci. Rep."},{"key":"4470_CR43","doi-asserted-by":"publisher","first-page":"6453","DOI":"10.2147\/OTT.S245336","volume":"13","author":"D Li","year":"2020","unstructured":"Li, D., Xing, Y., Tian, T., Guo, Y. & Qian, J. Overexpression of LRRC59 is associated with poor prognosis and promotes cell proliferation and invasion in lung adenocarcinoma. Onco Targets Ther. 13, 6453\u20136463 (2020).","journal-title":"Onco Targets Ther."},{"key":"4470_CR44","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1158\/0008-5472.CAN-21-0622","volume":"82","author":"U Ray","year":"2022","unstructured":"Ray, U. et al. Targeting LRRC15 inhibits metastatic dissemination of ovarian cancer. Cancer Res. 82, 1038\u20131054 (2022).","journal-title":"Cancer Res."},{"key":"4470_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3892\/ijo.2014.2418","volume":"45","author":"T Fujitomo","year":"2014","unstructured":"Fujitomo, T., Daigo, Y., Matsuda, K., Ueda, K. & Nakamura, Y. Identification of a nuclear protein, LRRC42, involved in lung carcinogenesis. Int. J. Oncol. 45, 147\u2013156 (2014).","journal-title":"Int. J. Oncol."},{"key":"4470_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/epigenomes4010001","volume":"4","author":"C Kenneth","year":"2020","unstructured":"Kenneth, C., Ehrlich, M. L. & Ehrlich, M. Epigenetics of skeletal muscle-associated genes in the ASB, LRRC, TMEM, and OSBPL gene families. Epigenomes 4, 1 (2020).","journal-title":"Epigenomes"},{"key":"4470_CR47","doi-asserted-by":"publisher","first-page":"967193","DOI":"10.3389\/fimmu.2022.967193","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang, L. & He, C. Nrf2-mediated anti-inflammatory polarization of macrophages as therapeutic targets for osteoarthritis. Front. Immunol. 13, 967193 (2022).","journal-title":"Front. Immunol."},{"issue":"13","key":"4470_CR48","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.18632\/aging.202505","volume":"17","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Macrophage migration inhibitory factor activates the inflammatory response in joint capsule fibroblasts following post-traumatic joint contracture. Aging 17(13), 5804\u20135823 (2021).","journal-title":"Aging"},{"key":"4470_CR49","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.ccell.2019.02.009","volume":"35","author":"L Cassetta","year":"2019","unstructured":"Cassetta, L. et al. Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming, biomarkers, and therapeutic targets. Cancer Cell 35, 588-602.e510 (2019).","journal-title":"Cancer Cell"},{"key":"4470_CR50","doi-asserted-by":"publisher","first-page":"23830","DOI":"10.1074\/jbc.M111.324947","volume":"287","author":"KA Donigan","year":"2012","unstructured":"Donigan, K. A. et al. Human POLB gene is mutated in high percentage of colorectal tumors. J. Biol. Chem. 287, 23830\u201323839 (2012).","journal-title":"J. Biol. Chem."},{"key":"4470_CR51","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/jso.21275","volume":"100","author":"M Iwatsuki","year":"2009","unstructured":"Iwatsuki, M. et al. A platinum agent resistance gene, POLB, is a prognostic indicator in colorectal cancer. J. Surg. Oncol. 100, 261\u2013266 (2009).","journal-title":"J. Surg. Oncol."},{"key":"4470_CR52","doi-asserted-by":"publisher","first-page":"144","DOI":"10.7150\/ijbs.10692","volume":"11","author":"X Tan","year":"2015","unstructured":"Tan, X. et al. Clinical significance of a point mutation in DNA polymerase beta (POLB) gene in gastric cancer. Int. J. Biol. Sci. 11, 144\u2013155 (2015).","journal-title":"Int. J. Biol. Sci."},{"key":"4470_CR53","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1109\/TCBB.2024.3395777","volume":"21","author":"R Alkhanbouli","year":"2024","unstructured":"Alkhanbouli, R. et al. Analysis of cancer-associated mutations of POLB using machine learning and bioinformatics. IEEE ACM Trans. Comput. Biol. Bioinform. 21, 1436\u20131444 (2024).","journal-title":"IEEE ACM Trans. Comput. Biol. Bioinform."},{"key":"4470_CR54","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/s41375-023-01902-3","volume":"37","author":"JY Teng","year":"2023","unstructured":"Teng, J. Y. et al. Targeting DNA polymerase beta elicits synthetic lethality with mismatch repair deficiency in acute lymphoblastic leukemia. Leukemia 37, 1204\u20131215 (2023).","journal-title":"Leukemia"},{"key":"4470_CR55","doi-asserted-by":"publisher","first-page":"1039009","DOI":"10.3389\/fimmu.2022.1039009","volume":"13","author":"S Zhao","year":"2022","unstructured":"Zhao, S., Goewey Ruiz, J. A., Sebastian, M. & Kidane, D. Defective DNA polymerase beta invoke a cytosolic DNA mediated inflammatory response. Front. Immunol. 13, 1039009 (2022).","journal-title":"Front. Immunol."}],"updated-by":[{"DOI":"10.1038\/s41598-025-29236-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04470-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04470-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04470-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T10:03:07Z","timestamp":1764064987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04470-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4470"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-04470-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"27 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-025-29236-3","URL":"https:\/\/doi.org\/10.1038\/s41598-025-29236-3","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study\u2019s data came from a European population via the publicly available GWAS database. Informed consent was obtained from the participants in the original study, which meant that ethics committee approval was not required for this aspect of the research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"22123"}}